Applied DNA Sciences (NASDAQ:APDN) Releases Quarterly Earnings Results, Misses Estimates By $0.24 EPS

Applied DNA Sciences (NASDAQ:APDN) announced its quarterly earnings data on Thursday. The technology company reported ($0.56) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.32) by ($0.24), Zacks reports. Applied DNA Sciences had a negative net margin of 203.76% and a negative return on equity of 111.18%.

Applied DNA Sciences Trading Down 8.2 %

Applied DNA Sciences stock traded down $0.02 during mid-day trading on Thursday, hitting $0.17. The company’s stock had a trading volume of 3,717,359 shares, compared to its average volume of 3,093,090. The stock’s fifty day moving average is $0.19 and its two-hundred day moving average is $0.52. The firm has a market capitalization of $9.61 million, a PE ratio of -0.03 and a beta of 0.37. Applied DNA Sciences has a 1 year low of $0.12 and a 1 year high of $14.40.

Applied DNA Sciences Company Profile

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.